---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-22-010817"
form_type: "8-K"
ticker: "WGS"
cik: "0001818331"
company_name: "GeneDx Holdings Corp."
filed_at: "2022-04-27T23:59:59+00:00"
generated_at: "2026-06-26T04:12:29.918397+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Sema4 shareholders approve GeneDx acquisition, authorize share increase to 1B

## Summary
- Stockholders approved shares for GeneDx acquisition: 178,157,301 for, 104,365 against.
- Approved PIPE investment issuance: 178,106,518 for, 153,719 against.
- Approved charter amendment increasing authorized Class A common from 380M to 1B shares.
- Elected three Class I directors to serve three-year terms expiring 2025.
- Ratified Ernst & Young as independent auditor for fiscal year 2022.

## SEC filing metadata
- accession: 0001628280-22-010817
- form_type: 8-K
- ticker: WGS
- cik: 0001818331
- company_name: GeneDx Holdings Corp.
- filed_at: 2022-04-27T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818331/000162828022010817/0001628280-22-010817-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818331/000162828022010817/smfr-20220427.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-22-010817
- JSON: https://secwatch.observer/filing/0001628280-22-010817.json
- Plain text: https://secwatch.observer/filing/0001628280-22-010817.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.